BLUE
bluebird bio
BLUE
BLUE
Delisted
BLUE was delisted on the 30th of May, 2025.
168 hedge funds and large institutions have $273M invested in bluebird bio in 2023 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 53 increasing their positions, 46 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
20% less call options, than puts
Call options by funds: $4.45M | Put options by funds: $5.56M
27% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 22
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
168
Holding in Top 10
1
Calls
$4.45M
Puts
$5.56M
Top Buyers
| 1 | +$7.21M | |
| 2 | +$6.83M | |
| 3 | +$4.59M | |
| 4 |
BL
Bleichroeder LP
New York
|
+$3.16M |
| 5 |
JFG
Jefferies Financial Group
New York
|
+$2.46M |
Top Sellers
| 1 | -$13M | |
| 2 | -$10.9M | |
| 3 | -$4.37M | |
| 4 |
Walleye Capital
New York
|
-$2.75M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$2.52M |